Gilder Gagnon Howe & Co’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3M Sell
1,074,592
-34,003
-3% -$479K 0.15% 104
2025
Q4
$15.9M Sell
1,108,595
-312,810
-22% -$5.41M 0.17% 103
2025
Q3
$26.9M Sell
1,421,405
-3,488,338
-71% -$57.5M 0.27% 82
2025
Q2
$105M Sell
4,909,743
-1,372,074
-22% -$20.4M 1.12% 23
2025
Q1
$82.4M Sell
6,281,817
-54,045
-0.9% -$802K 1.08% 29
2024
Q4
$85.2M Buy
6,335,862
+2,151,256
+51% +$34.6M 0.92% 35
2024
Q3
$88.8M Sell
4,184,606
-550,132
-12% -$9.91M 1.06% 27
2024
Q2
$74.9M Buy
4,734,738
+513,222
+12% +$9.43M 0.94% 33
2024
Q1
$62.8M Buy
4,221,516
+1,390,569
+49% +$19M 0.78% 39
2023
Q4
$25.9M Buy
2,830,947
+491,861
+21% +$3.39M 0.36% 70
2023
Q3
$13M Buy
2,339,086
+334,543
+17% +$2.34M 0.2% 94
2023
Q2
$16.2M Buy
2,004,543
+1,059,717
+112% +$7.82M 0.22% 94
2023
Q1
$6.18M Buy
+944,826
New +$3.86M 0.1% 127
2022
Q4
Sell
-149,491
Closed -$746K 258
2022
Q3
$746K Sell
149,491
-607,824
-80% -$3.55M 0.01% 206
2022
Q2
$3.22M Sell
757,315
-64,173
-8% -$408K 0.06% 159
2022
Q1
$8.19M Buy
821,488
+720,859
+716% +$5.36M 0.08% 152
2021
Q4
$790K Buy
+100,629
New +$1.26M ﹤0.01% 304
2021
Q2
Sell
-347,725
Closed -$9.35M 432
2021
Q1
$9.35M Buy
+347,725
New +$10.9M 0.05% 205

Other funds holding OSCR

Gilder Gagnon Howe & Co's OSCR Position: Q1 2026 in Review

Gilder Gagnon Howe & Co reduced its Oscar Health (OSCR) stake by 3.1% in Q1 2026, selling an estimated $479K and leaving 1,074,592 shares worth $12.3M. The position accounts for 0.15% of the portfolio, ranked #104.

Gilder Gagnon Howe & Co first reported a position in OSCR in Q1 2021 and has held it in 18 quarters since. The position peaked at $105M in Q2 2025. 331 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • Gilder Gagnon Howe & Co held 1,074,592 shares of Oscar Health worth $12.3M as of Q1 2026.
  • Gilder Gagnon Howe & Co sold 34,003 Oscar Health shares in Q1 2026, an estimated $479K.
  • Oscar Health made up 0.15% of Gilder Gagnon Howe & Co's portfolio in Q1 2026, its #104 holding.
  • Gilder Gagnon Howe & Co first reported a position in Oscar Health in Q1 2021 and has held it in 18 quarters since.
  • Gilder Gagnon Howe & Co's Oscar Health position peaked at $105M in Q2 2025.
  • 331 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2026, filed 15 May 2026.